Daria M. Grousova
Moscow, MOW 123098, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
A Lethal Pseudofilovirus Model in Ifnar1(-/-) Mice Using Recombinant Vesicular Stomatitis Viruses.
Journal: Viruses
Published: May 29, 2026
Long-term protective potency of AAV vector-based SARS-CoV-2 prophylaxis in mice and non-human primates.
Journal: Frontiers in immunology
Published: March 12, 2026
Structural Design of T-Cell Epitope-Based mRNA Vaccine Constructs Determines the Quality of T-Cell Immunity and Protective Efficacy Against SARS-CoV-2 in Mice.
Journal: Vaccines
Published: February 13, 2026
Broadly neutralizing single-domain antibody targeting the spike NTD displays therapeutic efficacy against diverse SARS-CoV-2 variants.
Journal: Frontiers in immunology
Published: January 29, 2026
Sputnik V update: safety and neutralizing antibodies in healthy adults and adolescents.
Journal: Frontiers in immunology
Published: October 31, 2025
Circular mRNA against CleanCap linear mRNA vectors: comprehensive comparison, expression, active and passive immunization.
Journal: Frontiers in immunology
Published: October 29, 2025
Adenoviral Vectors Expressing Optimized preM/E Genes of WNV Deliver Long-Term Protection Against Lethal West Nile Virus Challenge.
Journal: Vaccines
Published: October 27, 2025
Ultra-potent RBM-specific single-domain antibody broadly neutralizes multiple SARS-CoV-2 variants with picomolar activity.
Journal: International journal of biological macromolecules
Published: February 18, 2025
Safety and immunogenicity of GamEvac-Combi, a heterologous rVSV- and rAd5-vectored Ebola vaccine: a randomized controlled multicenter clinical trial in the Republic of Guinea and Russia.
Journal: Frontiers in immunology
Published: August 27, 2024
Immunogenicity and Protectivity of Sputnik V Vaccine in hACE2-Transgenic Mice against Homologous and Heterologous SARS-CoV-2 Lineages Including Far-Distanced Omicron BA.5.
Journal: Vaccines
Published: August 21, 2024
Safety and immunogenicity of rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine against SARS-CoV-2 in healthy adolescents: an open-label, non-randomized, multicenter, phase 1/2, dose-escalation study.
Journal: Frontiers in immunology
Published: May 24, 2023
rAAV expressing recombinant antibody for emergency prevention and long-term prophylaxis of COVID-19.
rAAV expressing recombinant antibody for emergency prevention and long-term prophylaxis of COVID-19.
Journal: Frontiers in immunology
Published: December 21, 2022
Last Updated: 09/26/2026